Eye Health
Life Biosciences' ER-100 Enters Phase 1 for Age-Related Vision Loss
The clinic entry marks a milestone for epigenetic reprogramming as a mechanism in age-related optic neuropathy — a cate…
Eye Health 2 stories
Eye Health
Gildeuretinol Enters Phase 3 Trial for Stargardt Disease
The deuterium-stabilized vitamin A analog moves into global pivotal testing, raising questions about regulatory classif…